Cantitate/Preț
Produs

Pharmacotherapy for Liver Cirrhosis and Its Complications

Editat de Xingshun Qi, Yongping Yang
en Limba Engleză Hardback – 27 iul 2022
This book aims to provide an updated information on different types of major and emerging drugs for managing liver cirrhosis and its complications, including acute gastroesophageal variceal bleeding, ascites, hepatic encephalopathy, liver failure, acute kidney injury, and portal venous thrombosis. The chapters are organized by drug class, such as anti-HBV drugs, anti-HCV drugs, anticoagulants, and antibiotics, etc. The clinical efficacy, indication, and contra-indication of the various drug therapies are discussed using supportive reference material from authoritative sources and published clinical trials. It will be an invaluable reference for physicians who are treating patients with liver cirrhosis, especially those presenting with acute life-threatening complications.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 71523 lei  38-44 zile
  Springer Nature Singapore – 28 iul 2023 71523 lei  38-44 zile
Hardback (1) 109322 lei  3-5 săpt.
  Springer Nature Singapore – 27 iul 2022 109322 lei  3-5 săpt.

Preț: 109322 lei

Preț vechi: 115076 lei
-5% Nou

Puncte Express: 1640

Preț estimativ în valută:
20937 21571$ 17539£

Carte disponibilă

Livrare economică 01-15 februarie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9789811926143
ISBN-10: 981192614X
Pagini: 240
Ilustrații: XII, 240 p. 20 illus., 16 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.59 kg
Ediția:1st ed. 2022
Editura: Springer Nature Singapore
Colecția Springer
Locul publicării:Singapore, Singapore

Cuprins

Anti-HBV drugs in liver cirrhosis.- Anti-HCV drugs in liver cirrhosis.- Anticoagulants in liver cirrhosis.- Antibiotics in liver cirrhosis.- Silymarin in liver cirrhosis.- Ursodeoxycholic acid in liver cirrhosis.- Emricasan in liver cirrhosis.- Non-selective beta blockers in liver cirrhosis.- Somatostatin and octreotide in liver cirrhosis.- Terlipressin in liver cirrhosis.- Diuretics in liver cirrhosis.- Statins in liver cirrhosis.- L-Ornithine L-Aspartate in liver cirrhosis.- Lactulose in liver cirrhosis.


Notă biografică

Xingshun Qi is an Associate Professor at the Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Yongping Yang is a Professor at Department of Liver Disease, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.

Textul de pe ultima copertă

This book aims to provide an updated information on different types of major and emerging drugs for managing liver cirrhosis and its complications, including acute gastroesophageal variceal bleeding, ascites, hepatic encephalopathy, liver failure, acute kidney injury, and portal venous thrombosis. The chapters are organized by drug class, such as anti-HBV drugs, anti-HCV drugs, anticoagulants, and antibiotics, etc. The clinical efficacy, indication, and contra-indication of the various drug therapies are discussed using supportive reference material from authoritative sources and published clinical trials. It will be an invaluable reference for physicians who are treating patients with liver cirrhosis, especially those presenting with acute life-threatening complications.

Caracteristici

Presents current and emerging pharmacotherapy for management of liver cirrhosis comprehensively Introduces indications and contra-indications of different types of drug in management of liver cirrhosis Supported by authoritative sources and published clinical trials